Richard D. Beger Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Branch Chief

National Center for Toxicological Research

faculty

48 h-index 220 pubs 13,311 cited

Research Areas

Metabolomics and Mass Spectrometry Studies Analytical Chemistry and Chromatography Pharmacological Effects and Toxicity Studies Health and Medical Research Impacts Molecular Biology Techniques and Applications Meta-analysis and systematic reviews

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Richard D. Beger's research focuses on the application of analytical chemistry techniques, particularly mass spectrometry-based untargeted metabolomics and lipidomics, within the field of regulatory toxicology and science. He has been involved in developing and refining methodologies for quality assurance and quality control in these analytical approaches, contributing to recommendations for analytical quality management and the establishment of reference materials.

His work also addresses the integration of emerging technologies into regulatory science. Beger has contributed to discussions on reporting frameworks for transcriptomics and metabolomics in regulatory toxicology, aiming to advance the use of these 'omics' technologies for predicting biological responses and informing regulatory decisions. His research network includes collaborators from the National Center for Toxicological Research, such as Lisa Pence, Amy L. Inselman, Kellie A. Woodling, and Gonçalo Gamboa da Costa.

With a career marked by significant scholarly output, Beger has authored or co-authored over 220 publications, accumulating more than 13,300 citations and an h-index of 48, designating him as a highly cited researcher. His recent publications explore topics ranging from quality control in metabolic phenotyping to the potential of metabolomics as a translational tool for precision medicine and the discovery of proteomic biomarkers.

Metrics

  • h-index: 48
  • Publications: 220
  • Citations: 13,311

Selected Publications

  • Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop (2025) DOI
  • Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers (2024) DOI
  • The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses (2024) DOI
  • Analysis types and quantification methods applied in UHPLC-MS metabolomics research: a tutorial (2024) DOI
  • Identification of Proteomic Biomarkers of Acetaminophen-Induced Hepatotoxicity Using Stable Isotope Labeling (2024) DOI
  • The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model (2024) DOI
  • Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples (2023) DOI
  • Metabolomics evaluation of the photochemical impact of violet-blue light (405 nm) on ex vivo platelet concentrates (2023) DOI
  • Prediction and Experimental Evaluation of the hERG Blocking Potentialof Drugs Showing Clinical Signs of Cardiotoxicity (2022) DOI
  • Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management (2022) DOI
  • Effects of Serum and Compound Preparation Methods on Delayed Repolarization Evaluation With Human iPSC-CMs (2022) DOI
  • Evaluating Cefoperazone-Induced Gut Metabolic Functional Changes in MR1-Deficient Mice (2022) DOI
  • Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC) (2022) DOI
  • Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy (2021) DOI
  • Identification of structural factors that affect binding to cannabinoid receptor type 1 (2021) DOI

Collaborators

Researchers in the database who share publications

Lisa Pence National Center for Toxicological Research 3 shared publications Amy L. Inselman National Center for Toxicological Research 2 shared publications Kellie A. Woodling National Center for Toxicological Research 2 shared publications Gonçalo Gamboa da Costa National Center for Toxicological Research 2 shared publications Vikrant Vijay National Center for Toxicological Research 2 shared publications Laura K. Schnackenberg National Center for Toxicological Research 2 shared publications Svetoslav Slavov National Center for Toxicological Research 2 shared publications E. Ellen Jones National Center for Toxicological Research 1 shared publication

Similar Researchers

Based on overlapping research topics

James Lp University of Arkansas for Medical Sciences
Metabolomics and Mass Spectrometry Studies Analytical Chemistry and Chromatography Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Sagaya Theresa Leena Philominathan University of Arkansas at Fayetteville
Pharmacological Effects and Toxicity Studies Health and Medical Research Impacts Molecular Biology Techniques and Applications
Good match 3 shared topics
Ngai Chung Neville Tam University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Health and Medical Research Impacts Molecular Biology Techniques and Applications
Good match 3 shared topics
Anna Mazur University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Health and Medical Research Impacts Molecular Biology Techniques and Applications
Good match 3 shared topics
Renny Shang-Lun Lan University of Arkansas for Medical Sciences
Metabolomics and Mass Spectrometry Studies Analytical Chemistry and Chromatography Health and Medical Research Impacts
Good match 3 shared topics
Ducu Onisei University of Arkansas for Medical Sciences
Metabolomics and Mass Spectrometry Studies Analytical Chemistry and Chromatography Pharmacological Effects and Toxicity Studies
Good match 3 shared topics